LncRNA TMEM99 Complexes with IGF2BP2 to Inhibit Autophagy in Lung Adenocarcinoma
Advanced Science · 2025
DOI: 10.1002/advs.202507871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Zhigang Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai…. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Adenocarcinoma of Lung, RNA, Long Noncoding, Autophagy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Sailing Program, Beijing Xisike Clinical Oncology Research Foundation.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD), the most common type of lung cancer, has a poor prognosis. Long noncoding RNAs (lncRNAs) play a key role in LUAD progression, yet the biological role of lncRNA TMEM99 remains unexplored. In this study, its function in inhibiting autophagy in LUAD is explored. Using RNA sequencing and quantitative reverse transcription PCR (qRT‐PCR), TMEM99 is found upregulated in LUAD tissues and cell lines, correlating with poor patient outcomes. In vivo and in vitro assays confirmed that TMEM99 promotes cell proliferation, migration, and invasion, and inhibits autophagy. Mechanistically, the 3′ end of TMEM99 binds to the K‑homology domain 1 (KH1) and KH4 domains of far upstream element‑binding protein 3 (FUBP3), stabilizing its protein. The TMEM99‐FUBP3 complex binds to p21 mRNA and recruits IGF2BP2 in an N⁶‑methyladenosine (m⁶A)‐dependent manner, which enhances mRNA stability and translation efficiency. This study reveals that TMEM99 plays a crucial regulatory role in LUAD autophagy and presents a novel cytoplasmic regulatory mechanism contributing to LUAD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
- Department of Thoracic Surgery I, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming, 650000, China.
- Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China.
- Department of Ultrasound, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
ORCID-Profile: Yihua Sun
Förderung
- Science and Technology Commission of Shanghai Municipality
- Shanghai Sailing Program
- Beijing Xisike Clinical Oncology Research Foundation
- National Science Fund for Distinguished Young Scholars
Zitieren
APA
Wu, Z., Zhao, Y., Peng, Y., Liu, P., Huang, Q., Wo, Y., Pan, Y., Zheng, D., Yuan, C., Shang, Y., Chen, X., Hong, H., & Sun, Y. (2025). LncRNA TMEM99 Complexes with IGF2BP2 to Inhibit Autophagy in Lung Adenocarcinoma. Advanced Science. https://doi.org/10.1002/advs.202507871
Vancouver
Wu Z, Zhao Y, Peng Y, Liu P, Huang Q, Wo Y, et al. LncRNA TMEM99 Complexes with IGF2BP2 to Inhibit Autophagy in Lung Adenocarcinoma. Advanced Science. 2025. doi:10.1002/advs.202507871
BibTeX
@article{Wu2025,
author = {Wu, Zhigang and Zhao, Yue and Peng, Yizhou and Liu, Pengcheng and Huang, Qixuan and Wo, Yang and Pan, Yunjian and Zheng, DongDong and Yuan, Chongze and Shang, Yan and Chen, Xiao and Hong, Hui and Sun, Yihua},
title = {LncRNA TMEM99 Complexes with IGF2BP2 to Inhibit Autophagy in Lung Adenocarcinoma},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202507871}
}
EUVIMED